Searched over 200M research papers for "mild cva"
9 papers analyzed
These studies suggest that cough variant asthma (CVA) is predominantly mild in children, improves with individualized treatment, and differs from classic asthma in clinical features and quality of life.
20 papers analyzed
Cough Variant Asthma (CVA) is a form of asthma where the primary symptom is a chronic cough, rather than the typical wheezing and shortness of breath associated with classic asthma. This condition is often considered a precursor to standard bronchial asthma (SBA) and is characterized by bronchial hyperresponsiveness (BHR) and airway inflammation.
Patients with mild CVA generally exhibit less severe symptoms compared to those with more severe forms of the condition. In a study involving Chinese pediatric patients, it was found that those with mild CVA (symptom score ≤3) showed significant improvement in symptoms and disease control within a shorter treatment period compared to those with severe CVA. Specifically, 98.6% of patients with mild CVA achieved disease control by the third week of treatment, and 99.7% by the seventh week.
Mild CVA is associated with less severe airway hyperresponsiveness and inflammation compared to moderate or severe asthma. Studies have shown that patients with mild CVA have higher forced expiratory volume in 1 second (FEV1) to forced vital capacity ratios and lower levels of airway obstruction markers . Additionally, the presence of eosinophilic inflammation, a common feature in asthma, is less pronounced in mild CVA .
Pulmonary function tests in patients with mild CVA often reveal near-normal spirometry results. These patients typically have higher methacholine PD20-FEV1 values, indicating less airway reactivity compared to those with more severe asthma . Furthermore, small airway dysfunction, although present, is less severe in mild CVA compared to typical asthma.
Nebulized BIS has been shown to be effective in managing symptoms of mild CVA. In a multi-center observational study, individualized BIS treatment based on the severity of baseline symptoms led to significant improvements in symptom control and reduced the need for bronchodilators in patients with mild CVA. Importantly, no severe or drug-related adverse events were reported, highlighting the safety of this treatment approach.
The dynamic changes in airway hyperresponsiveness in children with mild CVA indicate that the condition can improve rapidly with appropriate treatment. A study following children with CVA over six months found that airway hyperresponsiveness decreased significantly during the initial treatment phase, with many patients transitioning from moderate to mild or very mild hyperresponsiveness.
Mild CVA is a distinct form of asthma characterized by less severe symptoms, lower levels of airway hyperresponsiveness, and minimal eosinophilic inflammation. Effective management, particularly with treatments like nebulized BIS, can lead to rapid improvement in symptoms and disease control. Understanding the clinical characteristics and treatment responses of mild CVA is crucial for optimizing patient outcomes and preventing progression to more severe forms of asthma.
Most relevant research papers on this topic